ROP
54
-6
WRK
59
3
HON
53
-4
PPG
64
3
ILMN
38
2
ADT
28
3
CMS
54
-6
BRK.B
47
-3
INTU
69
2
ETN
87
4
RIG
50
4
PPL
52
-5
CAG
47
3
VLO
33
-2
MTCH
50
2
TROW
58
10
WEC
29
-5
T
41
2
BXP
47
-3
UAL
66
8
ROP
54
-6
WRK
59
3
HON
53
-4
PPG
64
3
ILMN
38
2
ADT
28
3
CMS
54
-6
BRK.B
47
-3
INTU
69
2
ETN
87
4
RIG
50
4
PPL
52
-5
CAG
47
3
VLO
33
-2
MTCH
50
2
TROW
58
10
WEC
29
-5
T
41
2
BXP
47
-3
UAL
66
8
Financhill
Back

Clearfield 10K Form

Buy
53

CLFD
Clearfield

Last Price:
29.51
Seasonality Move:
6.48%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CLFD News And Ratings

See the #1 stock for the next 7 days that we like better than CLFD

CLFD Financial Statistics

Sales & Book Value

Annual Sales: $268.72M
Cash Flow: $5.42M
Price / Cash Flow: 24.79
Annual Sales: $20.09
Price / Book: 1.45

Profitability

EPS (TTM): 0.81000
Net Income (TTM): $13.01M
Gross Margin: $85.28M
Return on Equity: 4.26%
Return on Assets: 3.69%

Clearfield Earnings Forecast

Key Clearfield Financial Ratios

  • The Gross Profit Margin over the past 35 years for CLFD is 31.74%.
  • The Selling, General & Administrative Expenses for CLFD have been equal to 17.86% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 2.71% of Operating Income.
  • The Net Earning history of CLFD is 12.11% of Total Revenues.
  • Per Share Earnings over the last 34 years have been positive in 19 years.

Clearfield Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Communications Equipment
Sector: Information Technology
Current Symbol: CLFD
CUSIP: 18482P
Website: seeclearfield.com

Debt

Debt-to-Equity Ratio: 0.02
Current Ratio: 11.09
Quick Ratio: 7.22

Price-to-Earnings

Trailing P/E Ratio: 13.6
Forward P/E Ratio: 15.87

CLFD Technical Analysis vs Fundamental Analysis

Buy
53
Clearfield (CLFD) is a Buy

Is Clearfield a Buy or a Sell?

  • Clearfield stock is rated a Buy
    The current Clearfield [CLFD] share price is $29.51. The Score for CLFD is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.